Related Experiment Videos

Differentiation of dys- and demyelination using diffusional anisotropy

J Ono1, K Harada, T Mano

  • 1Division of Pediatrics; Toyonaka Municipal Hospital, Osaka, Japan.

Pediatric Neurology
|January 1, 1997
PubMed

Insights

Magnetic resonance diffusion imaging aids in distinguishing childhood dysmyelination from demyelination. Diffusion weighted imaging reveals distinct patterns in Pelizaeus-Merzbacher disease versus Krabbe and Alexander diseases, aiding clinical diagnosis.

Area of Science:

  • Neuroimaging
  • Pediatric Neurology
  • Radiology

Background:

  • Differentiating between dysmyelination and demyelination in childhood is crucial for accurate diagnosis and treatment.
  • Both conditions can present with similar T2-weighted magnetic resonance imaging (MRI) findings in the cerebral white matter, posing a diagnostic challenge.

Observation:

  • Pelizaeus-Merzbacher disease (a dysmyelination disorder) shows diffuse high T2 signal with diffusion anisotropy on diffusion weighted imaging (DWI).
  • Demyelination disorders like Krabbe disease and Alexander disease-related disorder exhibit loss of diffusion anisotropy in T2 high-intensity lesions.
  • Krabbe disease lesions are typically high signal on DWI (high signal type), while Alexander disease-related disorder lesions are low signal on DWI (low signal type).

Findings:

  • Diffusion weighted imaging (DWI) can differentiate dysmyelination from demyelination in pediatric white matter lesions.
  • Specific DWI characteristics, including the presence or absence of diffusion anisotropy and signal intensity, are key discriminators.

Implications:

  • DWI offers a valuable, non-invasive tool for the differential diagnosis of pediatric white matter disorders.
  • This imaging technique can guide clinical management by accurately identifying the underlying myelination defect.

Related Concept Videos